These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 10796426

  • 1. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ, Sudlow CL, Dunbabin DW.
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [Abstract] [Full Text] [Related]

  • 2. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Sudlow CL, Mason G, Maurice JB, Wedderburn CJ, Hankey GJ.
    Cochrane Database Syst Rev; 2009 Oct 07; 2009(4):CD001246. PubMed ID: 19821273
    [Abstract] [Full Text] [Related]

  • 3. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
    Hankey GJ, Sudlow CL, Dunbabin DW.
    Stroke; 2000 Jul 07; 31(7):1779-84. PubMed ID: 10884487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evidence with antiplatelet therapy and ADP-receptor antagonists.
    Easton JD.
    Cerebrovasc Dis; 2003 Jul 07; 16 Suppl 1():20-6. PubMed ID: 12698015
    [Abstract] [Full Text] [Related]

  • 6. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.
    Health Technol Assess; 2004 Oct 07; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
    Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.
    Health Technol Assess; 2011 Sep 07; 15(31):1-178. PubMed ID: 21888837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Valentine N, Van de Laar FA, van Driel ML.
    Cochrane Database Syst Rev; 2012 Nov 14; 11(11):CD005449. PubMed ID: 23152231
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current oral antiplatelet agents to prevent atherothrombosis.
    Hankey GJ.
    Cerebrovasc Dis; 2001 Nov 14; 11 Suppl 2():11-7. PubMed ID: 11316917
    [Abstract] [Full Text] [Related]

  • 14. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS.
    Drugs Aging; 1999 Aug 14; 15(2):91-101. PubMed ID: 10495069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
    Montalescot G.
    Clin Cardiol; 2000 Nov 14; 23 Suppl 6(Suppl 6):VI-18-22. PubMed ID: 11129682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.